BNP Paribas Asset Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.25M | Sell |
91,692
-114,321
| -55% | -$10.5M | 0.01% | 738 |
|
|
2025
Q4 | $18.5M | Buy |
206,013
+114,426
| +125% | +$10.8M | 0.02% | 549 |
|
|
2025
Q3 | $9.02M | Sell |
91,587
-40,567
| -31% | -$4.02M | 0.02% | 443 |
|
|
2025
Q2 | $12.1M | Buy |
132,154
+35,881
| +37% | +$3.47M | 0.03% | 426 |
|
|
2025
Q1 | $10.9M | Sell |
96,273
-90,330
| -48% | -$9.66M | 0.03% | 430 |
|
|
2024
Q4 | $19.7M | Sell |
186,603
-5,572
| -3% | -$598K | 0.05% | 352 |
|
|
2024
Q3 | $20.7M | Sell |
192,175
-28,573
| -13% | -$3.12M | 0.05% | 301 |
|
|
2024
Q2 | $24M | Sell |
220,748
-1,894
| -0.9% | -$223K | 0.06% | 269 |
|
|
2024
Q1 | $29.4M | Sell |
222,642
-12,483
| -5% | -$1.56M | 0.08% | 258 |
|
|
2023
Q4 | $28.6M | Buy |
235,125
+63,499
| +37% | +$7.09M | 0.08% | 253 |
|
|
2023
Q3 | $19.3M | Buy |
171,626
+73,550
| +75% | +$9.34M | 0.06% | 297 |
|
|
2023
Q2 | $14.3M | Buy |
98,076
+79,992
| +442% | +$10.9M | 0.04% | 336 |
|
|
2023
Q1 | $2.34M | Buy |
18,084
+464
| +3% | +$58.3K | 0.01% | 649 |
|
|
2022
Q4 | $2.25M | Buy |
17,620
+11,018
| +167% | +$1.28M | 0.01% | 664 |
|
|
2022
Q3 | $690K | Sell |
6,602
-16,166
| -71% | -$1.77M | ﹤0.01% | 780 |
|
|
2022
Q2 | $2.39M | Buy |
22,768
+20,354
| +843% | +$2.41M | 0.01% | 686 |
|
|
2022
Q1 | $309K | Sell |
2,414
-13,809
| -85% | -$1.66M | ﹤0.01% | 822 |
|
|
2021
Q4 | $2M | Sell |
16,223
-9,118
| -36% | -$1.19M | 0.01% | 693 |
|
|
2021
Q3 | $3.6M | Buy |
25,341
+18,419
| +266% | +$2.71M | 0.01% | 595 |
|
|
2021
Q2 | $1.08M | Sell |
6,922
-952
| -12% | -$154K | ﹤0.01% | 753 |
|
|
2021
Q1 | $1.22M | Sell |
7,874
-421
| -5% | -$65.2K | 0.01% | 700 |
|
|
2020
Q4 | $1.24M | Buy |
8,295
+152
| +2% | +$21.5K | 0.01% | 679 |
|
|
2020
Q3 | $1.08M | Sell |
8,143
-120
| -1% | -$15.7K | 0.01% | 666 |
|
|
2020
Q2 | $958K | Buy |
8,263
+812
| +11% | +$93.6K | 0.01% | 624 |
|
|
2020
Q1 | $731K | Sell |
7,451
-128,180
| -95% | -$16.8M | 0.01% | 642 |
|
|
2019
Q4 | $19.7M | Buy |
135,631
+131,058
| +2,866% | +$18.1M | 0.13% | 205 |
|
|
2019
Q3 | $609K | Sell |
4,573
-1,937
| -30% | -$250K | ﹤0.01% | 721 |
|
|
2019
Q2 | $744K | Sell |
6,510
-18,339
| -74% | -$2.15M | 0.01% | 701 |
|
|
2019
Q1 | $3.08M | Sell |
24,849
-291,509
| -92% | -$33.1M | 0.03% | 544 |
|
|
2018
Q4 | $31.5M | Buy |
316,358
+25,683
| +9% | +$2.89M | 0.29% | 89 |
|
|
2018
Q3 | $37.1M | Sell |
290,675
-108,539
| -27% | -$12.9M | 0.29% | 89 |
|
|
2018
Q2 | $43.2M | Buy |
399,214
+38,370
| +11% | +$4.18M | 0.36% | 56 |
|
|
2018
Q1 | $38.2M | Buy |
360,844
+13,926
| +4% | +$1.62M | 0.32% | 68 |
|
|
2017
Q4 | $40.6M | Buy |
346,918
+2,765
| +0.8% | +$313K | 0.35% | 57 |
|
|
2017
Q3 | $39.1M | Buy |
344,153
+71,961
| +26% | +$8.31M | 0.33% | 64 |
|
|
2017
Q2 | $33.9M | Sell |
272,192
-84,572
| -24% | -$10M | 0.3% | 75 |
|
|
2017
Q1 | $42.3M | Sell |
356,764
-1,510
| -0.4% | -$171K | 0.39% | 58 |
|
|
2016
Q4 | $35.9M | Buy |
358,274
+163,505
| +84% | +$17.5M | 0.34% | 65 |
|
|
2016
Q3 | $24.6M | Sell |
194,769
-11,443
| -6% | -$1.41M | 0.21% | 112 |
|
|
2016
Q2 | $24.1M | Sell |
206,212
-280,247
| -58% | -$31.7M | 0.2% | 124 |
|
|
2016
Q1 | $50.4M | Buy |
486,459
+196,594
| +68% | +$19M | 0.43% | 50 |
|
|
2015
Q4 | $28.9M | Buy |
289,865
+2,290
| +0.8% | +$224K | 0.25% | 106 |
|
|
2015
Q3 | $26.2M | Buy |
287,575
+250,865
| +683% | +$25.1M | 0.23% | 118 |
|
|
2015
Q2 | $3.89M | Sell |
36,710
-2,548
| -6% | -$282K | 0.03% | 565 |
|
|
2015
Q1 | $4.48M | Buy |
39,258
+6,181
| +19% | +$705K | 0.03% | 519 |
|
|
2014
Q4 | $3.64M | Buy |
33,077
+49
| +0.1% | +$5.17K | 0.03% | 500 |
|
|
2014
Q3 | $3.23M | Sell |
33,028
-96,878
| -75% | -$9.53M | 0.03% | 529 |
|
|
2014
Q2 | $13.1M | Buy |
129,906
+7,939
| +7% | +$775K | 0.1% | 250 |
|
|
2014
Q1 | $11.2M | Buy |
121,967
+6,101
| +5% | +$562K | 0.08% | 268 |
|
|
2013
Q4 | $10.5M | Sell |
115,866
-11,997
| -9% | -$1.04M | 0.08% | 292 |
|
|
2013
Q3 | $10.2M | Buy |
127,863
+63,660
| +99% | +$5.01M | 0.08% | 278 |
|
|
2013
Q2 | $4.67M | Buy |
+64,203
| New | +$4.8M | 0.03% | 423 |
|
Other funds holding ZBH
VCM
VPM
BNP Paribas Asset Management's ZBH Position: Q1 2026 in Review
BNP Paribas Asset Management reduced its Zimmer Biomet (ZBH) stake by 55% in Q1 2026, selling an estimated $10.5M and leaving 91,692 shares worth $8.25M. The position accounts for 0.01% of the portfolio, ranked #738.
BNP Paribas Asset Management first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $50.4M in Q1 2016. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- BNP Paribas Asset Management held 91,692 shares of Zimmer Biomet worth $8.25M as of Q1 2026.
- BNP Paribas Asset Management sold 114,321 Zimmer Biomet shares in Q1 2026, an estimated $10.5M.
- Zimmer Biomet made up 0.01% of BNP Paribas Asset Management's portfolio in Q1 2026, its #738 holding.
- BNP Paribas Asset Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
- BNP Paribas Asset Management's Zimmer Biomet position peaked at $50.4M in Q1 2016.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.